News & Updates

Show Multimedia Only

Investigational TYK2 inhibitor looks good for atopic dermatitis

21 Jan 2026

The investigational tyrosine kinase 2 (TYK2) inhibitor ICP-332 shows promise in the treatment of atopic dermatitis (AD), with phase II data showing favourable safety profile and efficacy.

Investigational TYK2 inhibitor looks good for atopic dermatitis

21 Jan 2026

Ethosuximide not supported for IBS pain management

20 Jan 2026

The T-type calcium channel blocker ethosuximide has shown limited benefit in the treatment of irritable bowel syndrome (IBS)-related abdominal pain in a proof-of-concept study.

Ethosuximide not supported for IBS pain management

20 Jan 2026

Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome

20 Jan 2026 by

For vulnerable cancer patients undergoing chemotherapy, treatment with low-dose olanzapine works just as well as megestrol acetate in terms of promoting appetite and weight gain, as shown in a study.

Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome

20 Jan 2026

Does erythromycin/clindamycin resistance predict mortality in MSSA bacteremia?

20 Jan 2026

Clindamycin or erythromycin susceptibility does not appear to contribute to 30-day mortality in patients with MSSA bacteremia treated with cefazolin, reports a study.

Does erythromycin/clindamycin resistance predict mortality in MSSA bacteremia?

20 Jan 2026

Use of sacituzumab govitecan safe, efficacious in pretreated mBC

20 Jan 2026 by

A recent China study has provided further evidence on the real-world efficacy and safety of sacituzumab govitecan (SG) in HR+/HER2- and triple-negative breast cancer (TNBC) patients who have received at least three lines of prior therapy.

Use of sacituzumab govitecan safe, efficacious in pretreated mBC

20 Jan 2026

‘Difficult’ patients nag healthcare providers

20 Jan 2026

Healthcare providers at times perceive clinic patients as “difficult” to handle, according to a study. These patients tend to have depression, anxiety, chronic pain, personality disorders, and more symptoms.

‘Difficult’ patients nag healthcare providers

20 Jan 2026

Cruciferous veggies protective against breast cancer?

20 Jan 2026 by

An analysis using data from two large prospective studies demonstrates the protective effect of cruciferous vegetable consumption against breast cancer.

Cruciferous veggies protective against breast cancer?

20 Jan 2026

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

20 Jan 2026

Nonmetastatic breast cancer survivors who are genetically predisposed to having an excess body weight appear to be at increased risk of mortality, as shown in a study.

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

20 Jan 2026

Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia

20 Jan 2026 by

The use of metformin following antenatal corticosteroid (ACS), specifically betamethasone, significantly improves maternal glucose levels and lowers the risk of neonatal hypoglycaemia in preterm infants, according to a recent study.

Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia

20 Jan 2026

5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer

19 Jan 2026 by

Sentinel lymph node biopsy (SLNB) may be safely omitted after breast-conserving therapy in patients with early-stage, node-negative breast cancer, with 5-year data from the BOOG 13-08 trial showing no difference in regional recurrence-free and distant disease-free survival outcomes whether or not SLNB was performed.

5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer

19 Jan 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Investigational TYK2 inhibitor looks good for atopic dermatitis

Investigational TYK2 inhibitor looks good for atopic dermatitis

Ethosuximide not supported for IBS pain management

Ethosuximide not supported for IBS pain management

Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome

Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome

Does erythromycin/clindamycin resistance predict mortality in MSSA bacteremia?

Does erythromycin/clindamycin resistance predict mortality in MSSA bacteremia?

Use of sacituzumab govitecan safe, efficacious in pretreated mBC

Use of sacituzumab govitecan safe, efficacious in pretreated mBC

‘Difficult’ patients nag healthcare providers

‘Difficult’ patients nag healthcare providers

Cruciferous veggies protective against breast cancer?

Cruciferous veggies protective against breast cancer?

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia

Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia

5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer

5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer